Insider · CIK 0001653133

Harshbarger Benjamin

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001653133

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−33.3K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−55K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−263K sh	—	—	0
2025-03-21	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+263K sh	—	—	262,500
2024-02-08	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+175K sh	—	—	175,000
2023-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+90K sh	—	—	90,000
2022-03-01	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+55K sh	—	—	55,000
2021-06-08	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+200K sh	—	—	200,000
2021-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+400K sh	—	—	400,000
2020-06-11	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+45K sh	—	—	45,000
2019-05-09	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−212 sh	$1.22	−$258.64	3,683
2018-09-17	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−98 sh	$3.94	−$386.12	3,895
2018-05-15	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−150 sh	$4.15	−$622.5	3,993
2018-05-09	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−322 sh	$4.26	−$1,371.72	4,143
2018-04-01	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−52 sh	$3.50	−$182	4,465
2018-02-12	NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+45K sh	—	—	45,000
2017-10-06	NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+75K sh	—	—	75,000
2017-09-17	NOVELION THERAPEUTICS INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+337 sh	—	—	1,782
2017-09-17	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−109 sh	$7.08	−$771.72	1,673
2017-09-17	NOVELION THERAPEUTICS INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−337 sh	—	—	336
2017-05-15	NOVELION THERAPEUTICS INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+717 sh	—	—	1,677
2017-05-15	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−232 sh	$8.97	−$2,081.04	1,445
2017-05-15	NOVELION THERAPEUTICS INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−717 sh	—	—	0
2017-05-09	NOVELION THERAPEUTICS INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+349 sh	—	—	819
2017-05-09	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−113 sh	$9.42	−$1,064.46	706
2017-05-09	NOVELION THERAPEUTICS INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+375 sh	—	—	1,081
2017-05-09	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−121 sh	$9.42	−$1,139.82	960
2017-05-09	NOVELION THERAPEUTICS INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−349 sh	—	—	697
2017-05-09	NOVELION THERAPEUTICS INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−375 sh	—	—	1,122
2017-04-01	NOVELION THERAPEUTICS INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+178 sh	—	—	527
2017-04-01	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−57 sh	$10.74	−$612.18	470
2017-04-01	NOVELION THERAPEUTICS INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−178 sh	—	—	177
2016-12-22	NOVELION THERAPEUTICS INC.Stock Option (right to buy)A Award	See Remarks	AAward	+97.4K sh	—	—	97,400
2016-11-29	NOVELION THERAPEUTICS INC.A Award	See Remarks	AAward	+1,747 sh	—	—	1,747
2016-11-29	NOVELION THERAPEUTICS INC.Restricted Stock UnitsA Award	See Remarks	AAward	+3,366 sh	—	—	3,366
2016-11-29	NOVELION THERAPEUTICS INC.Restricted Stock UnitsA Award	See Remarks	AAward	+3,589 sh	—	—	3,589
2016-11-29	NOVELION THERAPEUTICS INC.Restricted Stock UnitsA Award	See Remarks	AAward	+1,777 sh	—	—	1,777
2016-11-29	NOVELION THERAPEUTICS INC.Restricted Stock UnitsA Award	See Remarks	AAward	+2,564 sh	—	—	2,564
2016-11-29	NOVELION THERAPEUTICS INC.Restricted Stock UnitsA Award	See Remarks	AAward	+5,230 sh	—	—	5,230
2016-11-29	NOVELION THERAPEUTICS INC.Restricted Stock UnitsA Award	See Remarks	AAward	+7,486 sh	—	—	7,486
2016-11-29	Aegerion Pharmaceuticals, Inc.D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−1,704 sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−25.5K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−15.1K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−1,817 sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−10.7K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−2,676 sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−14.3K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−1,701 sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−3,399 sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−30K sh	—	—	0

Recent filings

Accepted (ET)
Jan 234
Harshbarger Benjamin0000905148-26-000317
SEC(opens sec.gov)
Mar 254
Harshbarger Benjamin0001104659-25-027772
SEC(opens sec.gov)
Feb 124
Harshbarger Benjamin0001104659-24-014610
SEC(opens sec.gov)
Jun 64
Harshbarger Benjamin0001104659-23-068344
SEC(opens sec.gov)
Mar 34
Harshbarger Benjamin0001104659-22-030184
SEC(opens sec.gov)
Jun 104
Harshbarger Benjamin0001104659-21-079413
SEC(opens sec.gov)
Jun 24
Harshbarger Benjamin0001104659-21-075898
SEC(opens sec.gov)
Jun 124
Harshbarger Benjamin0001104659-20-072742
SEC(opens sec.gov)
May 134
Harshbarger Benjamin0001104659-19-028900
SEC(opens sec.gov)
Nov 54
Harshbarger Benjamin0001104659-18-066047
SEC(opens sec.gov)
Apr 34
Harshbarger Benjamin0001104659-18-022141
SEC(opens sec.gov)
Feb 144
Harshbarger Benjamin0001104659-18-009352
SEC(opens sec.gov)
Oct 104
Harshbarger Benjamin0001104659-17-061561
SEC(opens sec.gov)
Sep 194
Harshbarger Benjamin0001104659-17-057897
SEC(opens sec.gov)

Companies

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210